CHOvolution™ - Optimized yield across product classes

The CHOvolution™ cell lines from Celonic are highly stable upon scale-up and enable the best output worldwide for biopharma production performance. Typically, a product titer of more than 7 g/L for a monoclonal antibody can be achieved (figure 1).

The extremely high titers reduce significantly the size of the bioreactors needed, saving costs throughout product development, as well as production costs of the final product.